Glenview Capital Management, founded in 2000 by Larry Robbins (Trades, Portfolio), is a privately held investment management firm.
Robbins exited his position in Endo International PLCÂ (ENDP) with an impact of -2.39% on the portfolio.
It is a specialty healthcare company engaged in developing, manufacturing, marketing and distributing branded pharmaceutical and generic products, as well as medical devices.Â
GuruFocus gives the stock a profitability and growth rating of 4 out of 10 with ROE of -5.07% and ROA of -0.79% that are underperforming 83% of the companies in the industry. Financial strength has a rating of 5 out of 10, with a cash-to-debt of 0.03 that is far below the industry median of 3.32.
Andreas Halvorsen (Trades, Portfolio) is the largest shareholder of the company among the gurus with 2.03% of outstanding shares, followed by John Paulson (Trades, Portfolio) with 1.49%, George Soros (Trades, Portfolio) with 0.97%, John Griffin (Trades, Portfolio) with 0.92%, Wallace Weitz (Trades, Portfolio) with 0.31% and RS Investment Management (Trades, Portfolio) with 0.24%.
Robbins closed his position in Allergan PLCÂ (AGN) with an impact of -2.06% on the portfolio.
The company is engaged in the development, manufacturing, marketing, sale and distribution of generic, branded generic, brand name, biosimilar and over-the-counter pharmaceutical products. Fourth quarter net revenue from continuing operations increased 74%, and diluted EPS from continuing operations increased 33% year over year.
GuruFocus gives the stock a profitability and growth rating of 6 out of 10 with ROE of -5.65% and ROA of 3.21% that are underperforming 55% of the companies in the industry. Financial strength has a rating of 5 out of 10, with a cash-to-debt of 0.03 that is far below the industry median of 3.32.
The largest shareholder among the gurus are Vanguard Health Care Fund (Trades, Portfolio) with 2.78% of outstanding shares, followed by Andreas Halvorsen (Trades, Portfolio) with 1.51%, John Paulson (Trades, Portfolio) with 1.4%, Daniel Loeb (Trades, Portfolio) with 1.37%, Paul Singer (Trades, Portfolio) with 0.51% and John Griffin (Trades, Portfolio) with 0.51%.
The investor reduced his stake in Thermo Fisher Scientific Inc. (TMO) by 30.29% and the deal had an impact of -1.56% on the portfolio.
The company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics.
GuruFocus gives the stock a profitability and growth rating of 9 out of 10 with ROE of 9.56% and ROA of 4.74% that are outperforming 69% of the companies in the Global Diagnostics & Research industry. Financial strength has a rating of 7 out of 10, with a cash-to-debt of 0.04 that is far below the industry median of 3.87.
Robbins is the largest shareholder of the company among the gurus with 1.5% of outstanding shares, followed by PRIMECAP Management (Trades, Portfolio) with 1.36%, Vanguard Health Care Fund (Trades, Portfolio) with 0.78%, Pioneer Investments (Trades, Portfolio) with 0.57%, First Pacific Advisors (Trades, Portfolio) with 0.46% and Steven Romick (Trades, Portfolio) with 0.41%.
Robbins reduced his stake in Cadence Design Systems Inc. (CDNS) by 63.24% and the deal had an impact of -1.47% on the portfolio.
The company develops system design enablement, or SDE, solutions that its customers use to design whole electronics systems and increasingly small and complex integrated circuits, or ICs, and electronic devices.Â
GuruFocus gives the stock a profitability and growth rating of 7 out of 10 with ROE of -18.41% and ROA of 9.46% that are outperforming 78% of the companies in the industry. Financial strength has a rating of 8 out of 10, with a cash-to-debt of 2.04 that is far below the industry median of 14.04.
The largest shareholder among the gurus are Dodge & Cox with 4.71% of outstanding shares, followed by Larry Robbins (Trades, Portfolio) with 2.84%, RS Investment Management (Trades, Portfolio) with 1.44%, Columbia Wanger (Trades, Portfolio) with 1.03%, Mariko Gordon (Trades, Portfolio) with 0.94% and Jim Simons (Trades, Portfolio) with 0.41%.
Robbins exited his position in Teradyne Inc. (TER) with an impact of -1.15% on the portfolio.
The company is a supplier of automatic test equipment. It designs, develops, manufactures and sells automatic test systems and solutions, which are used to test semiconductors and wireless products.
GuruFocus gives the stock a profitability and growth rating of 7 out of 10 with ROE of -10.10% and ROA of 7.97% that are outperforming 67% of the companies in the industry. Financial strength has a rating of 9 out of 10 with a no debt.
NWQ Managers (Trades, Portfolio) is the largest shareholder of the company among the gurus with 3.27% of outstanding shares, followed by Chuck Royce (Trades, Portfolio) with 1.76%, Joel Greenblatt (Trades, Portfolio) with 1.39%, Jim Simons (Trades, Portfolio) with 0.58%, PRIMECAP Management (Trades, Portfolio) with 0.52% and Ken Fisher (Trades, Portfolio) with 0.16%.
Robbins reduced his stake in Flextronics International Ltd. (FLEX) by 26.62% and the deal had an impact of -1.05% on the portfolio.
The company is a provider of design, manufacturing, and supply chain services and solutions that span from sketch to scale; from conceptual sketch to full-scale production. Fourth quarter adjusted EPS grew 13% year over year and despite the lighter revenues, adjusted operating income only decreased $4 million compared to the same quarter last year with operating margin improvement of 30 basis points to 3%.
GuruFocus gives the stock a profitability and growth rating of 6 out of 10 with ROE of 21.35% and ROA of 4.21% that are outperforming 55% of the companies in the Global Contract Manufacturers industry. Financial strength has a rating of 6 out of 10, with a cash-to-debt of 0.58 that is below the industry median of 1.38.
Robbins is the largest guru shareholder with 10% of outstanding shares, followed by PRIMECAP Management (Trades, Portfolio) with 8.88%, Richard Pzena (Trades, Portfolio) with 1.04%, Jim Simons (Trades, Portfolio) with 0.72% and Charles Brandes (Trades, Portfolio) with 0.11%.
Robbins reduced his stake in PVH Corp. (PVH) by 44.03% and the deal had an impact of -0.97% on the portfolio.
It is a branded apparel company with a heritage dating back over 130 years. Its brand portfolio consists of nationally and internationally recognized brand names.
GuruFocus gives the stock a profitability and growth rating of 8 out of 10 with ROE of 10.96% and ROA of 4.49% that are outperforming 55% of the companies in the Global Apparel Manufacturing industry. Financial strength has a rating of 5 out of 10, with a cash-to-debt of 0.11 that is far below the industry median of 1.26.
Larry Robbins (Trades, Portfolio) is the largest shareholder of the company among the gurus with 2.98% of outstanding shares, followed by Sarah Ketterer (Trades, Portfolio) with 2.09%, Michael Dell (Trades, Portfolio) with 1.3%, Ray Dalio (Trades, Portfolio) with 0.28%, Steven Cohen (Trades, Portfolio) with 0.17% and John Keeley (Trades, Portfolio) with 0.09%.
